SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-001357
Filing Date
2019-11-21
Accepted
2019-11-21 19:52:20
Documents
1
Period of Report
2019-11-20

Document Format Files

Seq Description Document Type Size
1 form4-11212019_041106.html 4  
1 form4-11212019_041106.xml 4 3877
  Complete submission text file 0001415889-19-001357.txt   5319
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 384 OYSTER POINT BLVD. SUITE 8 SOUTH SAN FRANCISCO CA 94080
Business Address
SNODGRASS H. RALPH (Reporting) CIK: 0001415876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 191238453